Wildfire Smoke Raises Risks for Folks on Dialysis

Medically reviewed by Drugs.com.

By Cara Murez HealthDay Reporter

TUESDAY, Nov. 7, 2023 -- Exposure to wildfire-related air pollution in western states has taken its toll on U.S. patients who are on dialysis.

New research linked it to elevated risks of hospitalization and death in patients who were receiving in-center hemodialysis treatment in Washington, Oregon and California.

Wildfires have been increasing in frequency and severity.

The researchers studied nearly 80,000 patients who received dialysis treatment at 191 Fresenius Kidney Care clinics in the three states from 2005 to 2018.

The investigators looked at the risk of all-cause hospitalization and death associated with wildfire exposure, using two metrics: wildfire smoke and wildfire-related fine particulate matter.

Exposure to wildfire smoke was associated with a 3% higher risk of hospitalization the following day, the study found.

The risk of death rose 5% on the day of exposure. Exposure to fine particulate matter from the fires was linked to a similar increase in risk.

“This research sheds light on the health risks faced by hemodialysis patients during wildfire events,” corresponding author Hyeonjin Song said in an American Society of Nephrology news release about the study.

“The most recent U.S. National Climate Assessment suggests that wildfire seasons will continue to get longer with a corresponding increase in frequency and intensity of wildfire events in response to ongoing climate change," said Song, a doctoral student at the University of Maryland, College Park.

"We need to pay attention to how such hazards impact the most vulnerable among us and enhance our preparedness activities to minimize the disease burden,” she added.

The study findings were presented Thursday at a meeting of the American Society of Nephrology, in Philadelphia. Findings presented at medical meetings are considered preliminary until published in a peer-reviewed journal.

Sources

  • American Society of Nephrology, news release, Nov. 2, 2023
  • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords